Login to Your Account



Selecta Gets Third Collaboration With SAIC Malaria Subcontract

By Tom Wall


Wednesday, August 31, 2011
Selecta Biosciences Inc. has scored its third significant collaboration in the past 12 months with a subcontract from Science Applications International Corp. (SAIC), of McLean, Va., to develop a targeted synthetic vaccine particle (tSVP) product for malaria.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription